ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,220, issued on Sept. 8, was assigned to SARTORIUS BIA SEPARATIONS (Ajdovscina, Slovenia). "Purification process for lipid-membrane-enclosed... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,221, issued on Sept. 8, was assigned to MITO QUEST Co. LTD. (Seoul, South Korea). "Anti-inflammatory peptide and use thereof" was invented ... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,222, issued on Sept. 8. "Enhanced peptide constructs for albumin binding" was invented by Michael Farber (Livingston, N.J.). According to ... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,223, issued on Sept. 8, was assigned to Eligo Bioscience (Paris). "Chimeric receptor binding proteins for use in bacterial delivery vehicle... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,224, issued on Sept. 8, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh). "Targeting MY... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,225, issued on Sept. 8, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "Non-canonical SWI/SNF complex and uses thereof" was in... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,226, issued on Sept. 8, was assigned to Victor Chang Cardiac Research Institute (Sydney) and National Cerebral and Cardiovascular Center (Os... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,227, issued on Sept. 8, was assigned to Catalent Pharma Solutions LLC (Somerset, N.J.). "Decorin compositions and use thereof" was invented... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,228, issued on Sept. 8, was assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio). "Transforming growth factor ... Read More
ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,229, issued on Sept. 8, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Engineered NRG-1 variants with improved selectivity toward Erb... Read More